Interestingly, the robust “three-genes HCC biomarker” contains FCN3, PRC1, and CLEC1B, has very high diagnostic ability, and also possesses prognostic potential, i.e., they are significantly associated with survival of HCC patients as determined by univariate analysis. This evidence concerns the gene FCN3 and hepatocellular carcinoma.